Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Andersson, Malmo
Bengt Andersson, Malmo SE
| Patent application number | Description | Published |
|---|---|---|
| 20090022863 | Method of Packing a Food and of Heat Treating It for Purposes of Extending Its Shelf-Life - A method of packing a food, and heat treating the food for purposes of extending its shelf-life, in a packaging container made of a packaging laminate comprising a core layer of paper or paperboard and outer plastic coatings of polyethylene, preferably low density polyethylene. The filled and sealed packaging container is conveyed through a treatment chamber or tunnel comprising a heating zone in which the packaging container is heated to the desired treatment temperature, e.g. 80-100° C., a holding zone in which the packaging container is kept at the desired treatment temperature and a cooling zone, wherein the packaging container during both of these treatment phases is subjected to an outer support pressure of less than 0.5 bar, preferably 0.2-0.3 bar. | 01-22-2009 |
| 20090071103 | Method in hot filling of foods in a packaging container, as well as an apparatus therefor - A method involving the hot fill of foods in packaging containers constructed from a paperboard laminate comprises the food being filled in the packaging container with at least one component at a temperature of at least 80° C., but below 100° C., whereafter the packaging containers are closed and sealed and the packaging containers with their food contents are thereafter held hot during a predetermined period of time by contact with a heat holding medium at a temperature of at least 80° C., but below 100° C. The heat holding medium is present substantially in gas and/or vapour phase. An apparatus involving the hot fill of foods Information Disclosure Statement also disclosed. | 03-19-2009 |
Johan Andersson, Malmo SE
| Patent application number | Description | Published |
|---|---|---|
| 20080246685 | RADIO ANTENNA FOR A COMMUNICATION TERMINAL - A radio antenna device for a radio communication terminal, e.g. a mobile phone, comprising a flat ground plane, a first monopole antenna element in the form of a meandered antenna element, and a second monopole antenna element having a folded three-dimensional box-like shape. The meandered antenna element has a first radio signal feeding point disposed at the ground plane. Furthermore, the meandered antenna element is located in the same plane as said ground plane in a direction of extension of the ground plane. The folded three-dimensional box-like shaped antenna element has a second radio signal feeding point disposed at a support member of the ground plane. Furthermore, the folded three-dimensional box-like shaped antenna element is located adjacent to said meandered antenna element. The meandered antenna element is operable in the first frequency band region and the folded three-dimensional box-like shaped antenna element is operable in the second frequency band region. | 10-09-2008 |
| 20080246690 | ANTENNA FOR A COMMUNICATION TERMINAL - A radio antenna device for a radio communication terminal, e.g. a mobile telephone, comprising a flat ground plane and an antenna element having a radio signal feeding point disposed at the ground plane. The antenna element has a folded three dimensional box-like shape. The inventive antenna design provides for an antenna device with compact size, which at the same time is operable in UWB (Ultra Wideband) frequency regions. The antenna device may therefore advantageously be incorporated into a portable communication terminal such as a mobile telephone. | 10-09-2008 |
Kerstin Ingalill Andersson, Malmo SE
| Patent application number | Description | Published |
|---|---|---|
| 20090118330 | Diurea derivatives - The present invention relates to novel diurea derivatives that block intracellular signal transduction and thereby inhibit the production of pro-inflammatory cytokines, especially interleukin-2 (IL-2) and/or induce apoptosis in activated T-cells. It further discloses such a compound for use as a medicament, the use of said compound for the manufacturing of a medicament for the treatment of immune disorders which benefit from inhibition of production of IL-2 and other pro-inflammatory cytokines and/or induction of apoptosis in activated T-cells, a pharmaceutical composition comprising said compound and a method of treatment comprising administration of a pharmaceutically effective amount of said compound. | 05-07-2009 |
Magnus Andersson, Malmo SE
| Patent application number | Description | Published |
|---|---|---|
| 20090115862 | GEO-TAGGING OF MOVING PICTURES - Image acquisition equipment for moving images comprising a sensing unit for registering moving images; a positioning receiver for receiving data indicative of the geographical position of the image acquisition equipment; a processing unit for calculating the current geographical position of the image acquisition equipment from the data received by the positioning receiver and for recording of moving images registered by the sensing unit; where processing unit is adapted for calculating the geographical position of the image acquisition equipment during the recording of moving images and for associating the current calculated geographical position with the current time of recording of the moving images. | 05-07-2009 |
Tommy Andersson, Malmo SE
| Patent application number | Description | Published |
|---|---|---|
| 20080207521 | PEPTIDE LIGAND TO IMPAIR CANCER CELL MIGRATION - Loss of Wnt-5a protein expression in breast carcinoma patients is associated with a shorter recurrence-free survival as well as increased motility in mammary cell lines. Based on sequence analysis of Wnt-5a 13 peptide fragments were identified and investigated for their ability to mimic effects of the Wnt-5a protein on mammary cell adhesion and motility. Two of these peptides significantly increased adhesion and impaired the motility of non-tumourigenic breast cancer cell lines, both low in endogenous Wnt-5a protein expression. To identify the shortest possible peptide that still had an anti-motile effect, sequential deletions of two Wnt-5a protein expression. To identify the shortest possible peptide that still had an anti-motile effect, sequential deletions of two amino acids from the N-terminal side of the shorter of these two peptides were performed. The effect on tumour cell adhesion was gradually lost, and when only 6 amino acids remained the effect was not detectable. However, formulation of the N—terminal methionine of this hexapeptide restored its effect on adhesion and reduced tumour cell motility. The novel formyl-Met-Asp-Gly-Cys-Glu-Leu peptide ligand can serve as a lead substance for anti-metastatic treatment in the 50% of human breast cancers where the endogenous expression of Wnt-5a is reduced. | 08-28-2008 |
| 20110124574 | RESTORATION OF ESTROGEN RECEPTOR-(ALPHA) ACTIVITY - One third of all breast cancers are estrogen receptor alpha (ERα) negative, have a poor overall prognosis and do not respond well to currently available endocrine therapies. Use of a Wnt5-α protein or a peptide thereof, such as a recombinant Wnt-5a protein or a Wnt-5a derived hexapeptide (Foxy-5) possessing Wnt-5a signaling properties, enables restoration of ERα expression and makes it possible to treat such breast cancers with selective estrogen receptor modulators, such as tamoxifen, or aromatase inhibitors. | 05-26-2011 |